Torthaí cuardaigh - Norbert Meidenbauer

  • 1 - 7 toradh as 7 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients

    Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients de réir Norbert Meidenbauer, Joerg Marienhagen, Monika Laumer, Sandra Vogl, Jana Heymann, Reinhard Andreesen, Andréas Mackensen

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A Humanized Mouse Identifies the Bone Marrow as a Niche with Low Therapeutic IgG Activity

    A Humanized Mouse Identifies the Bone Marrow as a Niche with Low Therapeutic IgG Activity de réir Anja Lux, Michaela Seeling, Anne Baerenwaldt, Birgit Lehmann, Inessa Schwab, Roland Repp, Norbert Meidenbauer, Andréas Mackensen, Arndt Hartmann, Gordon F. Heidkamp, Diana Dudziak, Falk Nimmerjahn

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity

    ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity de réir Abbas Agaimy, Josephine K. Dermawan, Florian Haller, Sabine Semrau, Norbert Meidenbauer, Robert Stoehr, Sigurd Lax, Arndt Hartmann, Ying Zou, Deyin Xing, Lars Tögel, John Gross, Michael Michal

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites

    Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressiv... de réir Abbas Agaimy, Morgan Blakely, Gerben E. Breimer, Annett Hölsken, Sjors A. Koppes, Norbert Meidenbauer, Johannes A. Rijken, Arno Schad, Adrian Georg Simon, Robert Stoehr, Justin A. Bishop, Nasir Ud Din

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Inhibitory effect of tumor cell–derived lactic acid on human T cells

    Inhibitory effect of tumor cell–derived lactic acid on human T cells de réir Karin Fischer, Petra Hoffmann, Simon Voelkl, Norbert Meidenbauer, Julia Ammer, Matthias Edinger, Eva Gottfried, Sabine Schwarz, G. Rothe, Sabine Hoves, Kathrin Renner, Birgit Timischl, Andréas Mackensen, Leoni A. Kunz‐Schughart, Reinhard Andreesen, Stefan W. Krause, Marina Kreutz

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants

    Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants de réir Matthias Bieg, Evgeny A. Moskalev, Rainer Will, Simone Hebele, Matthias Schwarzbach, Sanja Schmeck, Peter Hohenberger, Jens Jakob, Bernd Kasper, Timo Gaiser, Philip Ströbel, Eva Wardelmann, Udo Kontny, Till Braunschweig, Horia Sı̂rbu, Robert Grützmann, Norbert Meidenbauer, Naveed Ishaque, Roland Eils, Stefan Wiemann, Arndt Hartmann, Abbas Agaimy, Karen Fritchie, Caterina Giannini, Florian Haller

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents

    The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents de réir Pauline Dürr, Katja Schlichtig, Carolin Kelz, Birgit Deutsch, Renke Maas, Michael J. Eckart, Jochen Wilke, Harald Wagner, Kerstin Wolff, Caroline Preuß, Valeska Brückl, Norbert Meidenbauer, Christian Staerk, Andreas Mayr, Rainer Fietkau, Peter J. Goebell, Frank Kunath, Matthias W. Beckmann, Andréas Mackensen, Markus F. Neurath, Marianne Pavel, Frank Dörje, Martin F. Fromm

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: